Skip Nav Destination
Article navigation
Other|
December 01 1986
Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?
F. Bochner
;
F. Bochner
1Department of Clinical and Experimental Pharmacology, University of Adelaide, and Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, Australia
Search for other works by this author on:
J. Lloyd
J. Lloyd
2Division of Haematology, Institute of Medical and Veterinary Science, Adelaide, Australia
Search for other works by this author on:
Clin Sci (Lond) (1986) 71 (6): 625–631.
Citation
F. Bochner, J. Lloyd; Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man?. Clin Sci (Lond) 1 December 1986; 71 (6): 625–631. doi: https://doi.org/10.1042/cs0710625
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Related Articles
Rapid and Selective Inhibition of Platelet Aggregation and Thromboxane Formation by Intravenous Low Dose Aspirin in Man
Clin Sci (Lond) (May,1993)
Separation of the impairment of haemostasis by aspirin from mucosal injury in the human stomach
Clin Sci (Lond) (October,1991)
Inhibition of platelet aggregation and thromboxane production by low concentrations of aspirin in vitro
Clin Sci (Lond) (May,1988)
Aspirin, Dipyridamole and Platelet Survival in Patients with Diabetes Mellitus
Clin Sci (Lond) (August,1982)